114 related articles for article (PubMed ID: 32352034)
1. Gas6 expression is reduced in advanced breast cancers.
Ibrahim AM; Gray Z; Gomes AM; Myers L; Behbod F; Machado HL
NPJ Precis Oncol; 2020; 4():9. PubMed ID: 32352034
[TBL] [Abstract][Full Text] [Related]
2. Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome.
Morales A; Rojo Rello S; Cristóbal H; Fiz-López A; Arribas E; Marí M; Tutusaus A; de la Cal-Sabater P; Nicolaes GAF; Ortiz-Pérez JT; Bernardo D; García de Frutos P
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33810394
[TBL] [Abstract][Full Text] [Related]
3. Identification and regulation of receptor tyrosine kinases Rse and Mer and their ligand Gas6 in testicular somatic cells.
Chan MC; Mather JP; McCray G; Lee WM
J Androl; 2000; 21(2):291-302. PubMed ID: 10714824
[TBL] [Abstract][Full Text] [Related]
4. Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets.
Uras F; Küçük B; Bingöl Özakpınar Ö; Demir AM
Turk J Haematol; 2015 Mar; 32(1):58-63. PubMed ID: 25805676
[TBL] [Abstract][Full Text] [Related]
5. Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor.
Hara T; Kimura A; Miyazaki T; Tanaka H; Morimoto M; Nakai K; Soeda J
Biochem Biophys Rep; 2020 Mar; 21():100726. PubMed ID: 32055714
[TBL] [Abstract][Full Text] [Related]
6. Growth arrest-specific gene 6 expression in human breast cancer.
Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; Goldrick AM; Dervan PA; Mc Cann A; Kerin MJ
Br J Cancer; 2008 Mar; 98(6):1141-6. PubMed ID: 18283315
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review.
Zhang S; Xu XS; Yang JX; Guo JH; Chao TF; Tong Y
Onco Targets Ther; 2018; 11():509-519. PubMed ID: 29416351
[TBL] [Abstract][Full Text] [Related]
8. Opposite trends of GAS6 and GAS6-AS expressions in breast cancer tissues.
Lavasani A; Hussen BM; Taheri F; Sattari A; Yousefi H; Omrani MD; Nazer N; Ghafouri-Fard S; Taheri M
Exp Mol Pathol; 2021 Feb; 118():104600. PubMed ID: 33359886
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights of Gas6/TAM in cancer development and therapy.
Wu G; Ma Z; Hu W; Wang D; Gong B; Fan C; Jiang S; Li T; Gao J; Yang Y
Cell Death Dis; 2017 Mar; 8(3):e2700. PubMed ID: 28333143
[TBL] [Abstract][Full Text] [Related]
10. Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.
Geng K; Kumar S; Kimani SG; Kholodovych V; Kasikara C; Mizuno K; Sandiford O; Rameshwar P; Kotenko SV; Birge RB
Front Immunol; 2017; 8():1521. PubMed ID: 29176978
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines.
Demarest SJ; Gardner J; Vendel MC; Ailor E; Szak S; Huang F; Doern A; Tan X; Yang W; Grueneberg DA; Richards EJ; Endege WO; Harlow E; Koopman LA
Biochemistry; 2013 May; 52(18):3102-18. PubMed ID: 23570341
[TBL] [Abstract][Full Text] [Related]
12. Gas6/AXL pathway: immunological landscape and therapeutic potential.
Zhai X; Pu D; Wang R; Zhang J; Lin Y; Wang Y; Zhai N; Peng X; Zhou Q; Li L
Front Oncol; 2023; 13():1121130. PubMed ID: 37265798
[TBL] [Abstract][Full Text] [Related]
13. Coordinated expression of tyro3, axl, and mer receptors in macrophage ontogeny.
Malawista A; Wang X; Trentalange M; Allore HG; Montgomery RR
Macrophage (Houst); 2016; 3():. PubMed ID: 27695708
[TBL] [Abstract][Full Text] [Related]
14. Engineered AXL
Duan Y; Hu B; Qiao C; Luo L; Li X; Wang J; Liu H; Zhou T; Shen B; Lv M; Feng J
Oncol Lett; 2019 Jun; 17(6):5784-5792. PubMed ID: 31186805
[TBL] [Abstract][Full Text] [Related]
15. The Involvement of GAS6 Signaling in the Development of Obesity and Associated Inflammation.
Wu KS; Hung YJ; Lee CH; Hsiao FC; Hsieh PS
Int J Endocrinol; 2015; 2015():202513. PubMed ID: 25954309
[TBL] [Abstract][Full Text] [Related]
16. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
[TBL] [Abstract][Full Text] [Related]
17. Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.
Lee HJ; Jeng YM; Chen YL; Chung L; Yuan RH
Carcinogenesis; 2014 Apr; 35(4):769-75. PubMed ID: 24233839
[TBL] [Abstract][Full Text] [Related]
18. AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.
Yan S; Vandewalle N; De Beule N; Faict S; Maes K; De Bruyne E; Menu E; Vanderkerken K; De Veirman K
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694201
[TBL] [Abstract][Full Text] [Related]
19. Gas6 Induces Myelination through Anti-Inflammatory IL-10 and TGF-β Upregulation in White Matter and Glia.
Goudarzi S; Gilchrist SE; Hafizi S
Cells; 2020 Jul; 9(8):. PubMed ID: 32722558
[TBL] [Abstract][Full Text] [Related]
20. Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis.
Shankar SL; O'Guin K; Kim M; Varnum B; Lemke G; Brosnan CF; Shafit-Zagardo B
J Neurosci; 2006 May; 26(21):5638-48. PubMed ID: 16723520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
